|
Testosterone Decreases
After Ingestion of Sugar
Click Here
|
High Glycemic Foods & Beverages are Related to
Low Testosterone Levels
Click
Here
|
Official Legal Claims
Document for
ArgMatrix™
Click
Here
|
ArgMatrix™ PASSESS
Independent Analytical
Screening for Steroids
and Illegal Anabolic
Substances.
Official Laboratory
Analytical Documents:
Click Here
|
No
company, other than
Boresha International,
may use
Dr. Ann de Wees Allen's
name on any L-Arginine product.
Click
Here
|
|
 |
 |
 |
 |
Boresha
International® announces the introduction of ArgMatrix™,
a State-of-the-Art L-Arginine Nitric Oxide formula backed
by 25-years of research and a full United States Patent. ArgMatrix™
contains the only form of L-Arginine that has been Patented
and proven to be safe long-term in humans.
|
ArgMatrix™
is the only Patented Edible Computer Chip® that delivers
a specific dose of an Arginine molecule to a targeted delivery
site in the human body. |
| • |
Formulated, researched and Patented by World renowned L-Arginine
researcher, Dr. Ann de Wees Allen® |
| • |
ArgMatrix™
contains Clinically Proven Levels of safe L-Arginine
|
| • |
ArgMatrix™
is the only Nitric Oxide L-Arginine product with
2 separate formulas – one specifically designed for the Female
Somatotype and one for the Male Somatotype |
| • |
ArgMatrix™
is the Key Code for generating Nitric Oxide in the
human body and contains the only Patented L-Arginine Key Code
signaling cell matrix |
| • |
ArgMatrix™
is Certified Low Glycemic |
| • |
ArgMatrix™
contains the only proven long-term safe form of L-Arginine,
ArgRX™, which is a unique form of pharmaceutical
grade L-Arginine bound to a Blind Amino Acid Rider. Click
Here |
| • |
ArgRX™
is the only form of L-Arginine that has been Patented
and proven to be safe long-term in humans, even at very high
doses (50 grams of elemental L-Arginine per day in humans). |
|
|
 |
All
forms of L-Arginine require a Blind Amino Acid Rider ®
in order to render arginine safe for use in humans |
|
| We
frequently get asked if men can use the ArgMATRIX™
Women's Formula and if women can use the ArgMATRIX™
Men's formula - the answer is YES
- it is perfectly safe to do so. |
|
|
|
 |
|
NITRIC
OXIDE
Nitric
Oxide (NO) is widely recognized as a key signaling molecule
in human health and is associated with a variety of tissues
and organs that affect cardiovascular disease, inflammatory
disease and male erectile dysfunction.
ArgRX™ research and patents focus on genetically-targeted
solutions for optimal health in humans, including L-Arginine
Nitric Oxide delivery systems. The unique and patented ArgRX™
Nitric Oxide (NO) transport systems provide a specific signaling
cell matrix designed to achieve appropriate cellular goals
and provide health benefits of NO.
Two of the Nitric Oxide (NO) patents and formulas, called
NO FOR HEALTH, are exclusively licensed to Boresha International,
and represents one of several technologies that ArgRX™
researchers developing for delivering NO to target tissues
for therapeutic benefit.
|
|
|
 |
Safe
Delivery of
Nitric Oxide & L-Arginine |
Since
its discovery as a signaling molecule 10 years ago, Nitric
Oxide (NO) has been demonstrated to be ubiquitous and essential
to a broad range of biological functions, but potentially
dangerous in human use (Johns Hopkins/JAMA).
ArgRX™ is the only long-term proven safe
delivery system for the amino acid L-Arginine. The patents
encompass the only Nitric Oxide (NO) formulas that contain
Blind Amino Acid® Riders, which render NO and L-Arginine
safe for human use long-term. Click
Here
|
|
|
 |
Creating
Safe
L-Arginine Formulas |
 |
The rate of
(Nitric Oxide) NO production is critically dependent on the
bioavailability of Arginine. NO is a highly reactive, short-lived,
lipophilic molecule with a half life of a few seconds. L-Arginine
Nitric Oxide (NO) formulas are capable of producing excessive
NO or reduced endogenous NO production.
Reduced arginine availability results in reduced NO synthesis.
Arginine availability for NO synthesis is regulated by de
novo arginine synthesis, arginase activity, and cellular
arginine transport. Arginase is generated by excessive NO
levels, and is to be avoided under any circumstance in an
L-Arginine or NO formula.
Excess (excessive) NO creates a toxic environment
in the human body, and low levels of NO (reduced
endogenous NO) are ineffective, so NO highs and lows are
to be avoided. In terms of fertility in males, NO reduces
or inhibits sperm motility, while NOS inhibitors, which
inhibit the formation of NO, prevent the reduction of sperm
motility, indicating a role for the L-arginine-NO pathway
in the modulation of sperm motility and motility survival.
Sperm motility is negatively affective by both reduced
and excessive endogenous Nitric Oxide (NO). The mechanism
of reduced fertility in males, related to NO, is
a function of the effect of reactive oxygen species (ROS)
on sperm membranes, which depresses sperm function. Stress
also exacerbates reduced motility of sperm. Excessive NO
levels in seminal plasma are associated with poor sperm
quality.
Excessive generation of NO can be toxic and reduce sperm
motility. Further, excessive NO contributes to the formation
of a highly toxic anion of peroxidation, called peroxynitrite.
The unpaired electrons of NO and O2 define peroxynitrite
as a 1-or-2-electron oxidant and nitrating agent, and not
a typical free radical.
Numerous clinical studies have demonstrated that peroxidation
decreases sperm count and motility, and loss of the capacity
of the spermatozoon to undergo the acrosome reaction and
fertilization.
Therefore, NO formulas and products must be produced under
strict GMP manufacturing guidelines utilizing long-term
proven methodologies in L-arginine biochemistry.
The manufacture of NO formulas and products should not
be attempted by persons unfamiliar with L-Arginine NO toxic
byproducts and the Blind Amino Acid personality
of amino acids, such as Arginine. Click
Here
|
|
|
 |
ArgMatrix™
contains the
Patented Compound ArgRX™ |
| ArgRX™
is the only Patented Edible Computer Chip® that delivers a
specific dose of an Arginine molecule to a targeted delivery
site in the human body.
ArgRX™
is the only L-Arginine compound on the market that has undergone
25-years of research to determine Arginine human dosing guidelines.
These specific dosing-guidelines are incorporated into every
ArgRX™
product.
The benefits of ArgRX™
are based on its unique and patented ability to deliver L-Arginine
to site-specific-destinations in the human body, and produce
the following actions:
• |
The
production of Nitric Oxide in elevating serum levels
of Arginine |
• |
Crosses the Blood-Brain-Barrier (BBB) |
• |
Stimulation
of muscle mitochondria |
|
|
|
 |
Unique
and Exclusive
Properties ofArgRX™ |
| • |
Patented Pharmaceutical-Grade
L-Arginine |
| • |
State-of-the-Art L-Arginine
|
| • |
The only proven
Safe L-Arginine (25 years) |
| • |
L-Arginine bound to
a Blind Amino Acid® Rider |
| • |
Patented Nitric Oxide
Formula |
| • |
The only Certified Low
Glycemic L-Arginine |
| • |
The only Certified Non-Cephalic
L-Arginine |
|
|
 |
| Essential
to any effective L-Arginine formula, is the ability to deliver
elemental Arginine to targeted sites in the body, utilizing
Threshold Plateau doses.
L-Arginine
benefits are dose and timing-dependent, and reach a Threshold
Plateau at specific elemental doses.
Effective
doses of L-Arginine range from 5,000 mg (5 grams) to 20,000
mg (20 g). Said doses must be ingested at one time.
Time-released
L-Arginine is not effective, as dosages must be delivered
and metabolized in 5-20 gram increments.
L-Arginine
must be administered in humans in elemental form. Elemental
refers to the net dose of an element, and not the gross weight.
Example: Many forms of L-Arginine contain 60 to 80 % pure
L-Arginine, and the rest is inert filler. If an L-Arginine
product label represents the gross weight and not the net
weight, the actual amount of L-Arginine is not represented
or known to the consumer.
If
the net dose of deliverable L-Arginine is less than 5
grams of elemental L-Arginine, the product cannot be
considered to be an efficacious L-Arginine formula.
In
calculating doses in L-Arginine products, there are 1000 mg
in a gram (g).
|
|
|
 |
| ArgRX™
is the first L-Arginine complex to contain Embedded Tracer
Technology (ETT). This allows tracking of authentic ArgRX™
products and formulas.
As
an Edible Computer Chip®, ArgRX™
is used as the base of many different Arginine formulas and
products. A Licensing Agreement is required for any use of
ArgRX™
in a product.
Any
formula or product that contains ArgRX™
is required to display the Official ArgRX™
logo on products and attendant marketing literature.
|
|
|
Backed
by United States Patent, Trademarks, and Copyrights.
No part of this website may be copied and placed on another
website, or used for any purpose whatsoever. |
|
These
statements have not been evaluated by the Food & Drug Administration.
The products promoted herein are not intended to diagnose, treat,
cure, or prevent any disease. |
|
